Antimicrobial catheters help prevent catheter-associated urinary tract infections (CAUTIs) with the emergence of antibiotic-resistant pathogens. Silver alloy-coated catheters have emerged as an effective alternative to conventional catheters owing to their broad-spectrum antimicrobial activity against both gram-positive and gram-negative bacteria. With rising prevalence of CAUTIs worldwide, adoption of antimicrobial catheters is increasing steadily. The global Antimicrobial Catheter Market is estimated to be valued at US$ 14,505.18 million in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing cases of antimicrobial resistance is one of the key drivers of the antimicrobial catheters market. According to the World Health Organization, antimicrobial resistance is threatening progress in modern medicine and is a global health emergency that requires coordinated action by all countries. With rising cases of infections caused by antibiotic-resistant bacteria, adoption of antimicrobial catheters is increasing as they help prevent catheter-associated UTIs. Antimicrobial catheter coatings prevent bacteria from adhering to and growing on the surface of the catheters, thereby significantly reducing the risks of catheter-associated infections. This is expected to accelerate revenue growth of the antimicrobial catheters market during the forecast period.
Segment Analysis
The global antimicrobial catheter market is segmented by type, indication, material, end user and region. Based on type, the hydrogel coated catheters segment dominated the market in 2024 and is expected to continue its dominance during the forecast period. Hydrogel coated catheters reduce the risk of catheter-associated urinary tract infections (CAUTIs) making them the preferred choice among healthcare providers.
Key Takeaways
The Global Antimicrobial Catheter Market Size is expected to witness high growth. Innovation cantered around developing more effective and affordable antimicrobial catheter technologies will fuel market growth over the forecast period.
Regional analysis: North America currently dominates the antimicrobial catheter market owing to rising incidence of hospital-acquired infections, presence of advanced healthcare infrastructure and favorable reimbursement policies. However, Asia Pacific is projected to witness the highest growth during the forecast period supported by increasing healthcare spending, large patient pool and growing awareness about prevention of hospital-acquired infections.
Key players: Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. These players are focusing on new product launches and collaborations to strengthen their market position. For instance, in 2022 Pendulum launched its FDA cleared antimicrobial foley catheter featuring AGION coating technology to reduce catheter-associated urinary tract infections.
Get More Insights Here
https://masstamilan.tv/industrial-dryers-advancing-process-efficiency-in-manufacturing-industries/
https://www.ukwebwire.com/antimicrobial-catheter-market-size-share-growth-outlook-2023/
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian